SCHEMBL2276188

SCHEMBL2276188

O=C(O)c1ccc(/C=C/CCc2ccccc2)cc1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
KCNA3 P22001 2/20 0.43
MAPT P10636 4/20 0.42
CYP1A2 P05177 3/20 0.42
HPGD P15428 3/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C19 P33261 2/20 0.42
SIRT5 Q9NXA8 1/20 0.42
ALDH1A1 P00352 3/20 0.40
LMNA P02545 3/20 0.40
MAPK1 P28482 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TRPA1 O75762 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
CDK2 P24941 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2276195 1.00 NPC1 (0.46) NPC1RAB9AKCNA3MAPTCYP1A2
SCHEMBL2276191 1.00 NPC1 (0.46) NPC1RAB9AKCNA3MAPTCYP1A2
SCHEMBL12394306 0.87 PRSS12 (0.45) NPC1RAB9AKCNA3MAPTCYP1A2
SCHEMBL2276972 0.84 KCNA3 (0.41) NPC1RAB9AKCNA3MAPTCYP1A2
SCHEMBL2276968 0.84 KCNA3 (0.41) NPC1RAB9AKCNA3MAPTCYP1A2
SCHEMBL12394313 0.81 PTPN1 (0.55) NPC1RAB9AMAPTHPGDALDH1A1
SCHEMBL14429394 0.81 SIRT5 (0.40) NPC1RAB9AKCNA3MAPTCYP1A2
SCHEMBL29393683 0.81 PTPN1 (0.49) NPC1RAB9AMAPTHPGDCYP3A4
SCHEMBL5146809 0.75 RXRA (0.51) NPC1RAB9AMAPTCYP1A2HPGD
SCHEMBL1515808 0.73 ALDH5A1 (0.62) MAPTHPGDCYP3A4ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 NPC1 4836/4885RAB9A 2238/4885KCNA3 3621/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.